Document is current
Any future updates will be listed below
-
Authors
Nunes, Allancer D. C.
Pitcher, Louise E.
Exner, Henry A.
Grassi, Diego J.
Burns, Brittan
Sanchez, Maria Beatriz Herrera
Tetta, Ciro
Camussi, Giovanni
Robbins, Paul D. https://orcid.org/0000-0003-1068-7099
-
Funding
Funding for this research was provided by:
National Institutes of Health (U19 AG056278, R01 AG069819, P01 AG062413, U54 AG079754, U54 AG076041, R01 AG063543)
Regione Piemonte (POR FESR 2014/2020)
- License Information
-
More Information
Article History
Accepted: 2 April 2025
First Online: 12 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: CT (Unicyte srl) is employed by commercial company and contributed to the study as a researcher. CT, and GC are named inventors in related patents. PDR is co-founder of Itasca Therapeutics, a start-up biotech company developing senolytics to extend healthspan, and a named inventor on multiple types of senolytic compounds.
